Timeliness of a potential automated system for national surveillance of healthcare-associated infections in England
Quan TP. et al, (2025), Journal of Hospital Infection, 161, 10 - 12
Transformers and large language models are efficient feature extractors for electronic health record studies
Yuan K. et al, (2025), Communications Medicine, 5
Machine learning and clinician predictions of antibiotic resistance in Enterobacterales bloodstream infections
Yuan K. et al, (2025), Journal of Infection, 90, 106388 - 106388
Addition of Macrolide Antibiotics for Hospital Treatment of Community-Acquired Pneumonia
Wei J. et al, (2024), The Journal of Infectious Diseases
Corrigendum to “No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia” [J Infect 88 (2024) 106161]
Wei J. et al, (2024), Journal of Infection, 89, 106361 - 106361
Predicting individual patient and hospital-level discharge using machine learning
Wei J. et al, (2024), Communications Medicine, 4
How, why and when are delayed (back-up) antibiotic prescriptions used in primary care? A realist review integrating concepts of uncertainty in healthcare
Mcleod M. et al, (2024), BMC Public Health, 24
Dissemination and persistence of antimicrobial resistance (AMR) along the wastewater-river continuum
Read DS. et al, (2024), Water Research, 264, 122204 - 122204
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
Naghavi M. et al, (2024), The Lancet, 404, 1199 - 1226
Why Was the Azithromycin “for Life” Trial Necessary?
Maitland K. and Walker AS., (2024), New England Journal of Medicine, 391, 760 - 762
Quantitative drug susceptibility testing for Mycobacterium tuberculosis using unassembled sequencing data and machine learning
(2024), PLOS Computational Biology, 20, e1012260 - e1012260
Retrospective analysis of hospital electronic health records reveals unseen cases of acute hepatitis with unknown aetiology in adults in Oxfordshire
Tan CCS. et al, (2024), BMC Public Health, 24
Nanopore sequencing of influenza A and B in Oxfordshire and the United Kingdom, 2022–23
Cane J. et al, (2024), Journal of Infection, 88, 106164 - 106164
A Phase I trial of Non-invasive Ventilation and seizure prophylaxis with levetiracetam In Children with Cerebral Malaria Trial (NOVICE-M Trial)
Maitland K. et al, (2024), Wellcome Open Research, 9, 281 - 281
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries
Kakaraskoska Boceska B. et al, (2024), Nature Communications, 15
Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection
Gu Q. et al, (2024), Journal of Infection, 88, 106156 - 106156
Author Correction: The plasmidome associated with Gram-negative bloodstream infections: a large-scale observational study using complete plasmid assemblies
Lipworth S. et al, (2024), Nature Communications, 15
Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection.
Gu Q. et al, (2024), The Journal of infection
No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia.
Wei J. et al, (2024), The Journal of infection, 88
OA-225 Optimising second line anchor drug options for children with HIV in Africa: 96 week results of the CHAPAS-4 randomised trial
Lugemwa A. et al, (2023), Abstracts of Oral Presentations, A8.1 - A8
Lineage replacement and evolution captured by 3 years of the United Kingdom Coronavirus (COVID-19) Infection Survey
Lythgoe KA. et al, (2023), Proceedings of the Royal Society B: Biological Sciences, 290
Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020-2022.
Harrison RE. et al, (2023), Emerging infectious diseases, 29, 2024 - 2031
When should factorial designs be used for late-phase randomised controlled trials?
White IR. et al, (2023), Clinical trials (London, England)
[A global core outcome measurement set for snakebite clinical trials].
Abouyannis M. et al, (2023), Medecine tropicale et sante internationale, 3
Challenges in the Implementation of the NeoOBS Study, a Global Pragmatic Observational Cohort Study, to Investigate the Aetiology and Management of Neonatal Sepsis in the Hospital Setting
Riddell A. et al, (2023), Antibiotics, 12, 923 - 923
Rise in alanine aminotransferase after HCV treatment is a highly sensitive screen for treatment failure.
Flower B. et al, (2023), Clinical liver disease, 21, 138 - 142
Risk of new-onset Long Covid following reinfection with SARS-CoV-2: community-based cohort study
Bosworth ML. et al, (2023)
Employment outcomes of people with Long Covid symptoms: community-based cohort study
Ayoubkhani D. et al, (2023)
Microbial diversity and antimicrobial resistance in faecal samples from acute medical patients assessed through metagenomic sequencing
Yokoyama M. et al, (2023), PLOS ONE, 18, e0282584 - e0282584
Enterobacterales plasmid sharing amongst human bloodstream infections, livestock, wastewater, and waterway niches in Oxfordshire, UK.
Matlock W. et al, (2023), eLife, 12
Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trial
Llewelyn MJ. et al, (2023), The Lancet Infectious Diseases, 23, 207 - 221
Impact of sub-optimal HIV viral control on activated T-cells: an earnest sub study.
Arrigoni FIF. et al, (2023), AIDS